As of April 2024 Xencor has a market cap of $1.16 Billion. This makes Xencor the world's 4919th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.16 B | -10.05% |
2023 | $1.29 B | -17.18% |
2022 | $1.56 B | -33.49% |
2021 | $2.34 B | -6.4% |
2020 | $2.50 B | 28.1% |
2019 | $1.95 B | -3.84% |
2018 | $2.03 B | 97.7% |
2017 | $1.02 B | -15.73% |
2016 | $1.22 B | 106.05% |
2015 | $0.59 B | 17.58% |
2014 | $0.50 B | 75.94% |
2013 | $0.28 B |
On Apr 24th, 2024 the market cap of Xencor was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $357.92 B | 30,689.00% | ๐บ๐ธ USA |
AbbVie ABBV | $297.11 B | 25,458.11% | ๐บ๐ธ USA |
Amgen AMGN | $146.43 B | 12,496.56% | ๐บ๐ธ USA |
Merck MRK | $321.69 B | 27,572.48% | ๐บ๐ธ USA |
Seagen
SGEN | $43.15 B | 3,612.21% | ๐บ๐ธ USA |
MacroGenics MGNX | $0.98 B | -15.51% | ๐บ๐ธ USA |